首頁 > 市場調查報告書 > 製藥

e保健處方藥

市場調查報告書

商品編碼

1572446

藥物管理系統市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Medication Management Systems Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月16日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在醫療技術進步、老年人口增加以及慢性病盛行率上升的推動下，全球藥物管理系統市場從 2024 年到 2032 年將呈現 9.8% 的複合年成長率。此外，電子健康記錄 (EHR) 和電子處方的日益普及進一步推動了這一成長。

隨著糖尿病和高血壓等慢性病變得越來越普遍，對長期藥物治療的需求也隨之增加。電子處方（e-prescribing）和電子健康記錄（EHR）在推動藥物管理系統產業方面發揮關鍵作用。這些技術確保無縫的用藥資訊整合，增強醫療保健提供者、藥房和患者之間的溝通，並保證準確、及時的用藥管理。

藥物管理系統市場根據軟體類型、部署模式、最終用途和區域進行分類。

市場將軟體類型分為臨床決策支援系統解決方案（CDSS）、庫存管理和供應鏈管理軟體、電腦化醫囑輸入（CPOE）、分流藥物管理、管理軟體、保證系統軟體和其他軟體類型。 2023 年，臨床決策支援系統解決方案 (CDSS) 部門以 11 億美元的收入領先。 CDSS 解決方案旨在透過在藥物處方和配藥期間為醫療保健專業人員提供即時、基於證據的指導來減少用藥錯誤。這些系統可以通知提供者潛在的藥物交互作用、過敏和禁忌症，從而避免有害的錯誤。鑑於醫療保健領域對用藥錯誤的持續關注，CDSS 在藥物管理中的日益採用凸顯了其日益成長的重要性。

藥物管理系統市場將部署模式分為基於雲端的解決方案、本地解決方案和基於網路的解決方案。 2023 年，基於雲端的細分市場以 48% 的佔有率引領市場。基於雲端的藥物管理系統提供無與倫比的可擴展性。這使得醫療保健提供者，從小型診所到廣闊的醫院網路，能夠根據需求調整他們的服務，而無需大量的前期基礎設施投資。這種適應性是基於雲端的解決方案採用激增的主要原因。

此外，基於雲端的系統無需昂貴的本地硬體、維護和 IT 支持，從而為醫療保健提供者節省大量成本。組織可以過渡到基於訂閱的模式，只需為他們使用的服務付費，而不是投資實體伺服器和軟體授權。這種財務優勢，特別是對於規模較小的提供者或預算緊張的提供者來說，將進一步推動該細分市場的成長。

2023年，北美藥物管理系統市場規模達17億美元，預計2024年至2032年複合年成長率為9.5%。這種先進的設置，加上早期採用藥物管理系統等創新解決方案的趨勢，凸顯了市場的成長。該地區慢性病盛行率高，需要複雜的用藥方案，這進一步強調了這些系統在確保依從性和盡量減少用藥錯誤方面的重要性。

產業生態系統分析
產業影響力
- 成長動力
  - 用藥錯誤不斷增加和病人安全需求
  - 醫療保健 IT 解決方案的採用率不斷提高
  - 提高醫院和藥局的自動化程度
- 產業陷阱與挑戰
  - 實施和維護成本高
成長潛力分析
監管環境
技術景觀
主要市場趨勢
波特的分析
PESTEL分析
差距分析
未來市場趨勢

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按軟體類型，2021 - 2032 年

主要趨勢
臨床決策支援系統解決方案（CDSS）
庫存管理和供應鏈管理軟體
電腦化醫囑輸入 (CPOE)
藥物轉移管理
管理軟體
- 條碼用藥記錄
- 電子用藥記錄
保障系統軟體
其他軟體類型

第 6 章：市場估計與預測：按部署模式，2021 - 2032 年

主要趨勢
基於雲端
本地部署
基於網路

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
藥局
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Becton, Dickinson and Company
Bluesight
Capsa Healthcare
eAgile Inc.
Epic Systems Corporation
GE HealthCare Technologies Inc.
GUARDIAN RFID
Impinj, Inc.
MCKESSON CORPORATION
Omnicell, Inc.
Oracle Corporation
RMS Omega
Swisslog Healthcare
Veradigm LLC
Yankee Alliance LLC.

簡介目錄

Product Code: 10832

The Global Medication Management Systems Market will exhibit a 9.8% CAGR from 2024 to 2032, driven by advancements in medical technology, a rising geriatric population, and the increasing prevalence of chronic diseases. Additionally, the growing adoption of electronic health records (EHRs) and e-prescribing further fuels this growth.

As chronic diseases like diabetes and hypertension become more prevalent, the demand for long-term medication therapy intensifies. Electronic prescribing (e-prescribing) and electronic health records (EHRs) play pivotal roles in propelling the medication management systems industry. These technologies ensure seamless medication information integration, enhancing communication among healthcare providers, pharmacies, and patients, and guaranteeing accurate and timely medication management.

The medication management systems market is categorized based on software type, deployment mode, end-use, and region.

The market categorizes software types into clinical decision support system solutions (CDSS), inventory management and supply chain management software, computerized physician order entry (CPOE), diversion medication management, administration software, assurance system software, and other software types. In 2023, the clinical decision support system solutions (CDSS) segment led the revenue generation with USD 1.1 billion. CDSS solutions aim to reduce medication errors by offering healthcare professionals real-time, evidence-based guidance during medication prescribing and dispensing. These systems can notify providers about potential drug interactions, allergies, and contraindications, thus averting harmful mistakes. Given the persistent concern of medication errors in healthcare, the rising adoption of CDSS in medication management underscores its growing importance.

The medication management systems market classifies deployment modes into cloud-based, on-premises, and web-based solutions. In 2023, the cloud-based segment led the market with a 48% share. Cloud-based medication management systems provide unmatched scalability. This allows healthcare providers, from small clinics to expansive hospital networks, to adjust their services based on demand without hefty upfront infrastructure investments. Such adaptability is a primary reason for the surge in cloud-based solution adoption.

Moreover, cloud-based systems negate the need for costly on-premises hardware, maintenance, and IT support, translating to substantial savings for healthcare providers. Organizations can transition to a subscription-based model, paying solely for the services they utilize, rather than investing in physical servers and software licenses. This financial advantage, especially appealing to smaller providers or those on tight budgets, is set to further propel the segment's growth in the market.

In 2023, North America medication management systems market accounted for a substantial USD 1.7 billion, with projections indicating a CAGR of 9.5% from 2024 to 2032. North America, and the U.S. in particular, boasts one of the globe's most sophisticated healthcare infrastructures. This advanced setup, coupled with a trend of early adoption of innovative solutions like medication management systems, underscores market growth. The region's high prevalence of chronic diseases, necessitating intricate medication regimens, further emphasizes the importance of these systems in ensuring adherence and minimizing medication errors.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising medication errors and need for patient safety
  - 3.2.1.2 Growing adoption of healthcare IT solutions
  - 3.2.1.3 Increasing hospital and pharmacy automation
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High implementation and maintenance costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Key market trends
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Software Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Clinical decision support system solutions (CDSS)
5.3 Inventory management and supply chain management software
5.4 Computerized physician order entry (CPOE)
5.5 Diversion medication management
5.6 Administration software
- 5.6.1 Barcode medication administration record
- 5.6.2 Electronic medication administration record
5.7 Assurance system software
5.8 Other software types

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Cloud-based
6.3 On-premise
6.4 Web-based

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Pharmacies
7.4 Ambulatory surgical centers
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa